Lifeboat Foundation

Researchers demonstrate a new fingerprinting attack on encrypted traffic using the Tor web browser.

The solid-state transformer is poised to remake the electrical distribution grid.

Are we governed by donkeys? COP26 was just a farce of vested interests kissing the butts of fossil fuel legacy industries that are so out of date that they cannot compete anymore and need underhand, secret handshake deals just to keep themselves in the luxury they enjoy…at our expense. So here is my Manifesto for the next decade. It is time to start voting for the right people and harassing your representatives to get them to make the right decisions that will benefit the majority, not a few CEO’s who are so corrupt it is like the plot of a new film…

The United States said Monday it was investigating a “debris-generating event in outer space” after astronauts on the International Space Station were forced to prepare for a possible evacuation. It came amid unconfirmed reports that Russia had carried out an anti-satellite weapon (ASAT) test…

“US Space Command is aware of a debris-generating event in outer space. We are actively working to characterize the debris field and will continue to ensure all space-faring nations have the information necessary to maneuver satellites if impacted,” the agency said.

“We are also in the process of working with… the State Department and NASA, concerning these reports and will provide an update in the near future.”

Continue reading “BREAKING ISS astronauts forced to board Crew Dragon and Soyuz to prepare for a possible evacuation” »

It is designed to activate white blood cells found in the lymph nodes on the sides and back of the neck to migrate to the brain and trigger clearance of beta-amyloid plaques — one of the hallmarks of Alzheimer’s. I-Mab Biopharma (I-Mab) and Jiangsu Nhwa Pharmaceutical (NHWA) are responsible for the development, manufacturing and commercialization of Protollin.

The trial represents the culmination of nearly 20 years of research led by Dr. Howard L. Weiner, co-director of the Ann Romney Center for Neurologic Diseases at the Brigham.

“The launch of the first human trial of a nasal vaccine for Alzheimer’s is a remarkable milestone,” said Weiner. “Over the last two decades, we’ve amassed preclinical evidence suggesting the potential of this nasal vaccine for AD. If clinical trials in humans show that the vaccine is safe and effective, this could represent a nontoxic treatment for people with Alzheimer’s, and it could also be given early to help prevent Alzheimer’s in people at risk.”

Pieces of a shattered Soviet-era satellite are visible in new telescope images after its destruction by a Russian anti-satellite weapons test on Monday (Nov. 15).

The images were captured by Numerica Corp., a Colorado-based company provides tracking of space debris objects, and shared by the company’s partner Slingshot Aerospace on Twitter. They show images and video of the debris in the wake of a direct-ascent anti-satellite test by Russia Monday that sent a missile from the ground to destroy a defunct satellite called Cosmos-1408.

The telescopic footage shows just some of the more than 1,500 trackable pieces of debris from Cosmos-1408 after its destruction by Russia. The U.S. Space Department, U.S. military officials and NASA administrator Bill Nelson are among the authorities condemning Russia for the act, which they said put the International Space Station at risk from the debris.

Continue reading “Space debris from Russian anti-satellite missile test spotted in telescope images and video” »

A woman in Argentina has become only the second documented person whose own immune system may have cured her of HIV.

SVT Robotics, a provider of software that orchestrates robots in warehouses and factories, has raised $25 million in series A funding led by Tiger Global with participation from Prologis Ventures, the company announced this morning. SVT says that it’ll use the new capital to bolster its product R&D and expand its customer outreach efforts.

According to cofounder and CEO A.K. Schultz, SVT’s platform helps customers to solve the growing “interoperability problem” in industrial automation. The industry is severely limited by its capacity to execute, he says. Integrations are typically custom-coded, translating to long, complex development cycles. A recent piece in Industry Today finds that factors ranking among the top concerns of manufacturers adopting automation include a lack of experienced workers to operate the machines, high transition expenses, and safety concerns.

“It’s expensive, and companies wait as much as a year or more for new automation to go live,” Schultz said in a statement. “Solving that problem with [SVT’s platform] empowers the market to grow at its full potential.”